Concepedia

Thorsten Kühn

TK

Statistics

Publications

72

Citations

6.4K

H-Index

34

Active since

1991

Affiliations

Klinikum Esslingen(Current)

University Hospital Schleswig-Holstein

University of Lübeck

Universität Ulm

German Breast group

Thorsten Kühn is an author at Klinikum Esslingen specializing in medicine, oncology, and breast oncology.

Publications per year

1991–2025

72

Publications

72

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Michael Untch, Mahdi Rezai, Sibylle Loibl et al. · Journal of Clinical Oncology · 2010 · 557 citations · Full text

, , +17

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Michael Untch, Peter A. Fasching, Gottfried E. Konecny et al. · Journal of Clinical Oncology · 2011 · 516 citations

, , +17

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

Michael Untch, Sibylle Loibl, Joachim Bischoff et al. · The Lancet Oncology · 2012 · 454 citations

, , +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

, , +17

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters

Andreas K. Buck, Holger Schirrmeister, Thorsten Kühn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 305 citations

, , +11

1–5 of 72